Under the Internal Revenue Code (“Code”) Section 162, ordinary and necessary business expenses are deductible, but Code Section 263 disallows a deduction for capital expenditures (“no deduction shall be allowed” for a capital...more
5/19/2021
/ Abbreviated New Drug Application (ANDA) ,
Audits ,
Business Expenses ,
Capital Expenditures ,
Depreciation ,
Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Internal Revenue Code (IRC) ,
IRS ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry